Posts for 10x Genomics, Inc. ($TXG)

Explore 10x Genomics' 2024 financial performance, revealing a hold recommendation amid solid revenue growth but significant losses and ongoing litigation risks.

Explore 10x Genomics, Inc.'s latest 8-K filing detailing corporate events, stock info, and regulatory compliance as of February 12, 2025. Essential insights for investors!

Discover crucial insights from 10x Genomics, Inc.'s 8-K filing dated January 12, 2025, including stock details and significant corporate events.